Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.
Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.
Japan’s largest women’s prison has become home to a growing number of seniors.
While the number of patients with flu are declining, a cold snap has again placed nurses under extreme stress.
The Safer Drugs Consumption Facility in Glasgow opened on 13 January, letting people take substances under supervision.
Trump has long been critical of how the Geneva-based institution handled the Covid-19 pandemic.
Experts in Leeds say new technology now allows them to reach previously "inoperable" tumours.
New weight-loss drugs have broad health benefits but also come with risks, researchers warn.
Ministers say previous government promise for 40 new hospitals by 2030 was undeliverable.
Women can ask for adjustments and this may encourage some people to get tested, the Eve Appeal says.